Stefan Allicock, Finance Expert in San Francisco, CA, United States
Stefan Allicock

Finance Expert in San Francisco, CA, United States

Member since February 27, 2020
With a Stanford MBA and more than eight years of experience working across investment banking, private equity, and corporate development, Stefan is an experienced consultant who brings a diverse financial skillset to Toptal's clients. Stefan has assisted an S&P 500 company with international acquisitions and strategic initiatives, as well as raising $50 million for a startup for fundraising efforts and business model expansion.
Stefan is now available for hire

Career Highlights

Education

Software Expertise

Other Expertise

Employment

  • Consultant

    2018 - PRESENT
    Independent Consulting
    • Provided financial modeling and due-diligence support to an S&P 500 listed medical device company that was pursuing several international acquisitions.
    • Constructed a detailed operating model and funding-needs model for an advertising technology startup (more than $50 million raised), that was used by executives for operational insights and future fundraising efforts.
    • Interviewed more than 100 executives, customers, and industry experts across several technology, healthcare, and industrial verticals for various due diligence related engagements.
    • Provided analytical and due diligence support to a private equity firm that was focused on the technology and the manufacturing sectors.
    • Gave acquisition due diligence and FP&A support to a sponsor-backed company that was pursuing a roll-up strategy, including traveling to Brazil to conduct due diligence on a potential acquisition.
    Focus areas: Financial Modeling, Focus Groups, Surveys, Primary Research, Due Diligence, Corporate Finance, Financial Planning & Analysis (FP&A)
  • Analyst

    2016 - 2016
    Newtyn Management
    • Served as the lead analyst on equity, credit and event-driven investments across all industries, with total exposure from investments greater than $100 million.
    • Led calls with company management, experts, customers, and competitors as well as other diligence efforts to construct projection models and develop investment theses.
    Focus areas: Equity Investment, Credit Analysis, Financial Modeling
  • Program Manager

    2015 - 2016
    Sponsors for Educational Opportunity
    • Developed the curriculum for and mentored individuals in both the alternative investments and careers programs which spanned investment banking, asset management, sales & trading, and equity research.
    Focus areas: Private Equity, Corporate Finance, Investment Banking
  • Private Equity Associate

    2013 - 2015
    Consonance Capital
    • Completed four acquisitions and worked on more than ten transactions that advanced to final bids across various healthcare verticals, including but not limited to, specialty pharmacy, medical management, dermatology, medical devices, and managed care.
    • Executed all elements of a $95-million transaction comprised of a carve-out of ExcelleRx and HP, the hospice pharmacy and PBM subsidiaries of Omnicare, and simultaneous merger with Enclara, a hospice pharmacy, including developing an operating model and LBO model, managing due diligence, coordinating with sell-side investment bankers and advisors, and putting together investment committee materials.
    • Executed all elements of a $24-million acquisition of KEPRO, a medical management company whose service offering includes medical appeals, medical review, utilization management, case management, chronic care management, and maternity management services.
    • Performed extensive buy-side diligence for a ~$170 million investment into a specialty pharmacy focused on the oncology, gastroenterology, rheumatology and dermatology therapeutic areas, including creating a bottom-up financial model, managing advisors, coordinating with sell-side investment bankers, and preparing investment committee materials that resulted in a final, binding bid.
    • Developed the firm's template LBO model.
    Focus areas: Private Equity, Private Equity Valuation, Investing, Healthcare
  • Investment Banking Analyst

    2011 - 2013
    Barclays
    • Advised healthcare companies on potential acquisitions and securities offerings, including IPOs and high-yield debt.
    • Performed valuation analyses, including discounted cash flow, LBO, sum-of-the-parts, ability-to-pay, accretion/dilution, comparable company, and precedent transactions.
    • Constructed a financial model and performed a tax-inversion deal structuring analysis for Perrigo Pharmaceuticals, an $8.6 billion acquisition of Elan.
    • Developed a leveraged buyout and financing model as well as participated in all aspects of a debt risk analysis, for One Equity Partner’s $1.1 billion buyout of M*Modal (Barclays declined to offer financing due to risks).
    Focus areas: Healthcare, Corporate Finance, Investment Banking, Mergers & Acquisitions (M&A)

Education

  • Master of Business Administration (MBA) Degree in General Management
    2016 - 2018
    Stanford University - Stanford, CA, USA
  • Bachelor's Degree in Economics
    2007 - 2011
    University of North Carolina at Chapel Hill - Chapel Hill, NC, USA
  • Bachelor's Degree in Business Administration
    2007 - 2011
    University of North Carolina at Chapel Hill - Chapel Hill, NC, USA

To view more profiles

Join Toptal
Share it with others